Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Heart protection capsule

A capsule and heart technology, applied in the field of biomedicine, can solve problems that cannot be solved fundamentally, increase the probability of suffering from other diseases, and cannot solve problems from the source, so as to eliminate hidden dangers of heart disease, increase myocardial oxygen supply, Restoring the effect of normal rheology

Inactive Publication Date: 2017-08-08
SHANGHAI TIANLONG BIOTECH CO LTD
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Cardiac stents and bypass surgery, which are the most widely used techniques in surgical treatment, can only provide temporary relief. They are standard methods for palliative care, not the root cause, but cause greater pain to patients
Surgical treatment has the following disadvantages: (1) only temporary relief can be obtained, and the problem cannot be fundamentally solved, and the symptoms are not cured; (2) the risk of surgery is high, and the probability of recurrence within a few years after surgery is extremely high, and it will also increase The probability of suffering from other diseases; (3) The cost of surgery is high, and the cost of maintenance is higher
However, the current surgical treatment method can only treat the symptoms but not the root cause, and can not solve the problem from the source, and the cost is high, which brings a huge economic burden to ordinary families; the current drug treatment can only temporarily relieve the symptoms, and the side effects are large. At the same time, it brings hidden dangers to the human body such as liver, kidney and stomach

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Example 1, a heart-protecting capsule of the present invention contains 44.55 mg of coenzyme Q10, 117 mg of α-linolenic acid and 32.5 mg of vitamin E. The coenzyme Q10 is extracted from plants, and the α-linolenic acid is obtained from Extracted from perilla oil, the vitamin E comes from natural vitamin E. The capsule can also include linoleic acid, oleic acid, palmitic acid, stearic acid, Vc, Ve, β-carotene, diterpene, furanuraldehyde, anthocyanin, calcium, iron, potassium, etc.

[0030] A heart-protecting capsule of the present invention has the following advantages:

[0031] 1. The raw materials of this patented product come from natural sources, the cost is low, the curative effect is remarkable, and there is no any side effect.

[0032] 2. Fundamentally repair damaged myocardial cells, increase myocardial oxygen supply, enhance blood oxygen carrying capacity, restore normal blood rheology, effectively prevent sudden heart disease, especially play a key role in the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a heart protection capsule. Specifically, the capsule contains coenzyme Q, alpha-linolenic acid and vitamin E, wherein the coenzyme Q10 and the alpha-linolenic acid are in a mass ratio of 0.3808+ / -0.05, and the coenzyme Q10 and vitamin E are in a mass ratio of 1.3708+ / -0.5202. The heart protection capsule is based on plant extracted coenzyme Q10 and perilla oil extracted alpha-linolenic acid, and is supplemented by natural vitamin E. The reasonable collocation of coenzyme Q and alpha-linolenic acid can regulate blood lipid and blood pressure while strengthening heart and protecting the cardiovascular system, and can fundamentally eliminate the hidden danger of heart diseases caused by high blood pressure and high blood lipid; the hydrolysis product tocopherol of vitamin E can protect effective components in the capsule from being oxidized; and the scientific and reasonable formula effectively avoids the toxic and side effect and irreversible harm brought about by the traditional cardiovascular drug treatment, and makes up for a number of disadvantages in drug and surgical treatment.

Description

[0001] Technical field: [0002] The invention relates to the technical field of biomedicine, in particular to a capsule for protecting the heart. [0003] Background technique: [0004] Heart disease is a relatively common circulatory system disease. The circulatory system is composed of the heart, blood vessels, and neurohumoral tissues that regulate blood circulation. Circulatory system diseases are also called cardiovascular diseases, including diseases of all the above-mentioned tissues and organs. They are common diseases in internal medicine, among which heart disease is the most common. Can significantly affect patient labor. [0005] For more and more cardiovascular diseases, the current clinical treatment methods are divided into two types: drug treatment and surgical treatment. Heart stents and bypass surgery, which are the most commonly used techniques in surgical treatment, can only provide temporary relief. They are standard methods for treating symptoms but not...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/122A61K31/202A61K31/355A61K9/48A61P3/06A61P9/12A61P9/00
CPCA61K9/4841A61K31/122A61K31/202A61K31/355A61K2300/00
Inventor 何小梅何小松袁希望
Owner SHANGHAI TIANLONG BIOTECH CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products